Register for our free email digests:
Array BioPharma Inc.
Division of Pfizer Inc.
www.arraybiopharma.com
Latest From Array BioPharma Inc.
Brighter News For Varlitinib As Results In Tough Cancer Type Encourage ASLAN
Following a major setback in another indication earlier this year, ASLAN’s lead asset is now seen as a potential new option for second-line use in biliary tract cancer following promising new data from a Chinese trial.
Celgene's Otezla Sale Shows FTC Wants Merging Companies To Ditch Marketed, Not Pipeline, Products
Companies used to be able to pick which overlapping products to divest to get US Federal Trade Commission merger approval but an FTC study showed certain divestitures weren't working.
Tecentriq Takes EU Lead In Triple-Negative Breast Cancer
Roche’s checkpoint inhibitor has been approved in combination with nab-paclitaxel in the EU for triple-negative breast cancer, cementing the company’s role as an innovator in breast cancer therapies.
Finance Watch: Gene Therapy, Targeted Oncology Driving IPOs Despite Biopharma Stock Shakiness
Public Company Edition: Jefferies report notes robust IPO market, but SVB Leerink predicts a financing slowdown. Also, Mirati raises cash for KRAS programs after Amgen's ASCO data and a strategic shift results in job cuts at ImmunoGen.
Company Information
- Industry
-
Biotechnology
- Drug Discovery Tools
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Cardiovascular
- Infectious & Viral Diseases
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Pfizer Inc.
- Senior Management
-
Ron Squarer, CEO
Jason Haddock, CFO
Andrew Robbins, COO
Nicholas A Saccomano, PhD, CSO
Victor Sandor, MD, CMO - Contact Info
-
Array BioPharma Inc.
Phone: (303) 381-6600
3200 Walnut St.
Boulder, CO 80301
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice